Coronary Heart Disease (CHD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com

Coronary heart disease (CHD) stands as the leading global cause of mortality, particularly escalating with age and displaying higher age-adjusted rates in men compared to women. Factors contributing to coronary risks encompass socioeconomic elements, traditional risk factors like hypertension and diabetes, lifestyle choices, and familial predisposition. Various triggers, including emotional stress or intense physical exertion, can precipitate coronary events. The underlying cause of CHD lies in the narrowing of coronary arteries, resulting in an imbalance between the heart’s functional needs and the arteries’ capacity to supply blood and oxygen. This imbalance leads to damage to the heart muscle, eventually manifesting as clinical symptoms. The clinical spectrum of CHD encompasses stable or unstable angina pectoris, myocardial infarction, cardiac arrhythmias, congestive heart failure, and sudden cardiac death, with predominant symptoms being thoracic pain and dyspnea. Over the long term, CHD is associated with disability, compromised health-related quality of life, and premature mortality.
• In the United States, the estimated prevalence of coronary heart disease is 2,929 per 100,000 individuals.

Thelansis’s “Coronary Heart Disease (CHD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Coronary Heart Disease (CHD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Coronary Heart Disease (CHD) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Coronary Heart Disease (CHD) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Coronary Heart Disease (CHD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033